10/8/2015
1
From Gums to Guts:Periodontal Medicine
KEY SLIDES
UCSF Osher Mini-Medical School
October 15, 2015
Mark I. Ryder DMD
Professor and Chair of Periodontology
Director, Postgraduate Program in Periodontology
AlveolarBone
(Offenbacher S. Scientific American 2006 (October);Special Supplement, pp. 24-29.)
ToothEnamel(Crown)
Root ofTooth
DentalBiofilm
(Dental Plaqueand Calculus)
Periodontal Pocket(with ulcerated wall)
bacteria diseasehost response
environmental factors(smoking)
genetic factors(IL-1 beta)
systemic factors(diabetes)
psychological factors(stress)
10/8/2015
2
1. Systemic conditions and medications that have oral manifestations
2. Factors that affect the oral cavity and other areas of the body with similar mechanisms
3. Periodontal/Oral conditions that may have systemic effects
Systemic conditions, diseases and medications (e.g. pregnancy, diabetes,
HIV, etc.)
Periodontal Diseases
Systemic conditions diseases (e.g.
cardiovascular diseases, diabetes, pregnancy
outcomes, etc.)
Periodontal Diseases
Systemic conditions, diseases
Periodontal Diseases
Tobacco, Age, etc..
.
Systemic conditions, diseases and medications (e.g. pregnancy, diabetes,
HIV, etc.)
Periodontal Diseases
.
1. Systemic conditions and medications that have oral manifestations
2. Factors that affect the oral cavity and other areas of the body with similar mechanisms
3. Periodontal/Oral conditions that may have systemic effects
10/8/2015
3
Systemic conditions, diseases
Periodontal Diseases
Tobacco, Age, etc.
1. Systemic conditions and medications that have oral manifestations
2. Factors that affect the oral cavity and other areas of the body with similar mechanisms
3. Periodontal/Oral conditions that may have systemic effects
Systemic conditions diseases (e.g.
cardiovascular diseases, diabetes, pregnancy
outcomes, etc.)
Periodontal Diseases
.
Kurt H. Thoma (1883-1972)
Thoma KH. Secondary complications (Chapter VIII). In:Oral Abscesses, Ritter & Company, Boston, 1916, pp. 84-143.
circa 1950 )
10/8/2015
4
Potential Associations Between Periodontal Infections and Adverse Systemic Outcomes
(still unresolved)
• Heart DiseasesCoronary heart disease (Atherosclerosis)
• Adverse Pregnancy OutcomesPreterm birth; PreeclampsiaFetal growth restriction
Potential Associations Between Periodontal Infections and Adverse Systemic Outcomes(stronger evidence up to one year ago, now
unresolved)
• Diabetes Mellitus (Onset & Control)
Potential Associations Between Periodontal Infections and Adverse Systemic Outcomes
(stronger evidence)
• Pulmonary DiseasesAspiration & Ventilator-associated pneumoniaChronic obstructive pulmonary disease
Potential Associations Between Periodontal Infections and Adverse Systemic Outcomes
(older and newer directions)
• GI diseases and conditions• Rheumatoid Arthritis• Neurological Diseases
Cerebrovascular disease (nonhemorrhagic stroke)Brain abscessesAlzheimer’s diseaseMeningitis
• HIV and Dementia
10/8/2015
5
How do we determine a direct relationship vsa casual association?
• Association Studies
• Biological Mechanisms
• Effects of Periodontal Treatment
Potential Associations Between Periodontal Infections and Adverse Systemic Outcomes
(still unresolved)
• Heart DiseasesCoronary heart disease (Atherosclerosis)
• Adverse Pregnancy OutcomesPreterm birth; PreeclampsiaFetal growth restriction
How do we determine a direct relationship vsa casual association?
• Association Studies
• Biological Mechanisms
• Effects of Periodontal Treatment
Forest Plot from Meta-Analysis of Studies Dealing with the Associationof Periodontitis as a Risk Factor for Coronary Heart Disease
Khader et al. J Periodontol 2004;75:1046-1053.
Greater risk with periodontitis
10/8/2015
6
How was the disease measured?1. Self reported?2. Loss of clinical attachment, radiographic bone
loss?3. Plaque and Inflammation?
Pretreatment One-year post SRP & 3-monthrecalls
Dr. Robert Parr Dr. Robert Parr
Levels of inflammation/Gingval Index and Bleeding on Probing
How was the disease measured?1. Self reported?2. Loss of clinical attachment, radiographic bone
loss?3. Plaque and Inflammation?
How do we determine a direct relationship vsa casual association?
• Association Studies
• Biological Mechanisms
• Effects of Periodontal TreatmentHansson et al. Nature Reviews Immunology 6, 508-519 (July 2006) | doi:10.1038/nri1882
10/8/2015
7
Hansson et al. Nature Reviews Immunology 6, 508-519 (July 2006) |
doi:10.1038/nri1882
IL-1, IL-6, CRP, Collagenase (MMP’s)
Hansson et al. Nature Reviews Immunology 6, 508-519 (July 2006) | doi:10.1038/nri1882
(Data from: Tonetti et al. N Engl J Med 2007;356:911-920.)
**
* P < 0.05(Between Groups)
0 Day 1 Day 2 1 Mo 2 Mo 6 Mo
Flow-mediated dilatation was used as theprimary outcome and is considered an
index of endothelial dysfunction.
10/8/2015
8
Common Risk Factors/ Risk Indicators for Periodontal Diseases and Cardiovascular Diseases
1. Age2. Gender3. Educational Status4. Tobacco Use5. Hypertension6. C-reactive Protein Levels7. LDL/ cholesterol levels8. Genetics/ Inflammatory response
True Endpointsvs.
Surrogate Endpoints
For Periodontology: Loss of tooth due to periodontal disease
vs. loss of clinical attachment
For Cardiovascular Disease: Heart Attack or Stroke
vs.Levels of CRP ,Lipid Profiles, etc.
“Observational studies to date support an association between Periodontal Diseases and Atherosclerotic Vascular Diseases independent of known confounders. They do not, however, support a causative relationship.
Although periodontal interventions result in a reduction in systemic inflammation and endothelial dysfunction in short-term studies, there is no evidence that they prevent Atherosclerotic Vascular Diseases or modify its outcomes”
AHA Scientific Statement
Periodontal Disease and Atherosclerotic Vascular Disease: Does the Evidence Support an Independent Association?A Scientific Statement From the American Heart Association
Potential Associations Between Periodontal Infections and Adverse Systemic Outcomes
(still unresolved)
• Heart DiseasesCoronary heart disease (Atherosclerosis)
• Adverse Pregnancy OutcomesPreterm birth; PreeclampsiaFetal growth restriction
10/8/2015
9
From Offenbacher Scientific American 2006
Meta-analysis plot for overall adverse pregnancy outcome (preterm birth <37 weeksand spontaneous abortions/stillbirths). Polyzos et al. BMJ 2010;341:c7017.
Treatment No Treatment(Events/Total) (Events/Total)
López et al. 2002 15/200 20/200López et al. 2005 25/580 21/290Sadatmansuri et al. 2006 0/15 3/15Offenbacher et al. 2006 9/40 14/34Tarranum & Faizuddin 2007 55/120 70/100Oliveira et al. 2010 29/122 35/124SUBTOTAL 133/1077 163/763
Jeffcoat et al. 2003 5/123 11/123Michalowicz et al. 2006 49/413 52/410Offenbacher et al. 2009 98/903 80/903Newnham et al. 2009 54/546 55/541Macones et al. 2010 81/376 68/380SUBTOTAL 287/2361 266/2357
TOTAL ALL STUDIES 420/3438 429/3120
Courtesy of Gary Armitage
Odds Ratio (95% CI)
“LOW QUALITY”TRIALS
“HIGH QUALITY”TRIALS
0.1 0.2 0.5 1 2 5 10Favors Treatment Favors No Treatment
68%69.6%
45.9%
10%
BASELINEBASELINE 6 MONTHS~ 6 MONTHSApatzidou & Kinane. J ClinPeriodontol 2004;31:132-140.
Michalowicz et al. N Engl JMed 2006;355:1885-1894.
RESULTS OFPERIODONTAL
TREATMENTIN OPT STUDY
TYPICAL(EXPECTED)RESULTS OFSCALING &
ROOT PLANING
N = 20N = 413
HOW EFFECTIVE WAS THE PERIODONTAL TREATMENT?
Special Thanks to Gary Armitage for this slide
Potential Associations Between Periodontal Infections and Adverse Systemic Outcomes
(stronger evidence)
• Pulmonary DiseasesAspiration & Ventilator-associated pneumoniaChronic obstructive pulmonary disease
• Diabetes Mellitus (Onset & Control)
10/8/2015
10
Potential Associations Between Periodontal Infections and Adverse Systemic Outcomes(stronger evidence up to 3 weeks ago, now
unresolved)
• Diabetes Mellitus (Onset & Control)
DiabetesPeriodontal Diseases
infection inflammatory mediators (IL-1, IL-6, TNF-alpha)
insulin resistance
glucose
HbA1C
AGE’s (advanced glycation end products)
AGE-protein
thickening of blood vessel wallsinflammatory mediators (IL-1, IL-6, TNF-alpha)oxidative stress
proteins
hemoglobin
% reduction in Glycated Hemoglobin
• Periodontal Treatment 0.4-1.0
• Injected Insulin (1921) ≥2.5
• Inhaled Insulin (2006) 1.5
• Sulfonylureas (1946) 1.5
• Metformin (Bisguanide) (1995) 1.5
• Rosiglitazone (1999) 0.8-1.0
• DPP-IV Inhibitors (2006) 0.5-0.9
Modified from From Nathan DM 2007, NEJM
10/8/2015
11
(From: Engebretson et al. J Am Med Assoc 2013; 310:2523-2532.)
“Nonsurgical periodontal therapy did not improve glycemic control in patientswith type 2 diabetes and moderate to advanced chronic periodontitis. Thesefindings do not support the use of nonsurgical periodontal treatment in patients with diabetes for the purpose of lowering levels of HbA1c.”
DiabetesPeriodontal Diseases
Obesity
Potential Associations Between Periodontal Infections and Adverse Systemic Outcomes
(stronger evidence)
• Pulmonary DiseasesAspiration & Ventilator-associated pneumoniaChronic obstructive pulmonary disease
Potential Associations Between Periodontal Infections and Adverse Systemic Outcomes
(older and newer directions)
• GI diseases and conditions
• Rheumatoid Arthritis• Neurological Diseases
Cerebrovascular disease (nonhemorrhagic stroke)Brain abscessesAlzheimer’s diseaseMeningitis
• HIV and Dementia
10/8/2015
12
Potential Associations Between Periodontal Infections and Adverse Systemic Outcomes
(older and newer directions)
• GI diseases and conditions• Rheumatoid Arthritis
• Neurological DiseasesCerebrovascular disease (nonhemorrhagic
stroke)Brain abscessesAlzheimer’s diseaseMeningitis
• HIV and Dementia
Potential Associations Between Periodontal Infections and Adverse Systemic Outcomes
(older and newer directions)
• GI diseases and conditions• Rheumatoid Arthritis• Neurological Diseases
Cerebrovascular disease (nonhemorrhagic stroke)Brain abscessesAlzheimer’s diseaseMeningitis
• HIV and Dementia
Cognitive Function/Dementia
Periodontal Diseases
HIV
10/8/2015
13
++
Inflammatory Cytokines
++
++
F. NucleatumT. DenticolaP. Gingivalis
F. NucleatumT. DenticolaP. Gingivalis
Inflammatory Cytokines